RT Journal Article
SR Electronic
T1 825 α-CD38 therapy reverses α-PD1 resistance when used in a proper biologic schedule; explaining and overcoming previous failures of the combination in clinical trials
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A923
OP A923
DO 10.1136/jitc-2023-SITC2023.0825
VO 11
IS Suppl 1
A1 Priestley-Milianta, Christopher
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A923.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.